NFL BIOSCIENCES (EPA:ALNFL)

REGULATED PRESS RELEASE

published on 03/29/2024 at 17:45, 2 years 6 months ago

NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF

published on 03/11/2024 at 09:00, 2 years 7 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP

NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF

published on 03/11/2024 at 09:00, 2 years 7 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS

Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 7 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 7 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE

published on 02/13/2024 at 18:45, 2 years 8 months ago

NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT
Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme

NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 8 months ago

NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH
NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2

NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 8 months ago

NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME
NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer

NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 8 months ago

NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment

NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 8 months ago

NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA
NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique

NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action

Published on 10/26/2026 at 14:10, 2 hours 21 minutes ago

China XLX Announces 2026 9M Results
Published on 10/26/2026 at 13:30, 3 hours 1 minute ago

Stabilis Solutions Announces Third Quarter 2026 Conference Call and Webcast Date
Published on 10/26/2026 at 13:00, 3 hours 31 minutes ago

BTU Commences Initial Drill Program on Hubcap Project Adjacent to RPX in Wawa
Published on 10/26/2026 at 13:00, 3 hours 31 minutes ago

GameSquare Closes FanEngine Transaction
Published on 10/26/2026 at 12:30, 4 hours 1 minute ago

Longview Capital Announces Voluntary TSXV Delisting

View all ACCESSWIRE

Published on 10/26/2026 at 16:15, 15 minutes ago

Freedom Holding Corp. Advances AI Infrastructure Development in Kazakhstan
Published on 10/26/2026 at 15:18, 1 hour 12 minutes ago

EQS-Adhoc: Fraport AG Frankfurt Airport Services Worldwide: Preliminary Figures 3Q 2026
Published on 10/26/2026 at 14:43, 1 hour 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/26/2026 at 14:36, 1 hour 54 minutes ago

Original-Research: Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/26/2026 at 14:33, 1 hour 57 minutes ago

UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT

View all EQS

Published on 10/26/2026 at 11:27, 5 hours 3 minutes ago

261026 BENETEAU Transactions sur actions propres
Published on 10/26/2026 at 07:30, 9 hours 1 minute ago

EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 9 hours 1 minute ago

LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
Published on 10/23/2026 at 20:33, 2 days 19 hours ago

Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 2 days 19 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026

View all LES ECHOS COMFI WIRE

News